SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "LAR1:oru ;pers:(Söderquist Bo 1955)"

Sökning: LAR1:oru > Söderquist Bo 1955

  • Resultat 1-10 av 156
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Afshar, Mastaneh, et al. (författare)
  • Complete Genome Sequences of Two Staphylococcus saccharolyticus Strains Isolated from Prosthetic Joint Infections
  • 2021
  • Ingår i: Microbiology Resource Announcements. - : American Society for Microbiology. - 2576-098X. ; 10:10
  • Tidskriftsartikel (refereegranskat)abstract
    • Staphylococcus saccharolyticus is a human skin bacterium and is occasionally associated with prosthetic joint infections (PJIs). Here, we report the complete genome sequences of two strains that were isolated from shoulder and hip PJIs. The genomes show signs of reductive evolution; around 21% of all coding sequences are inactivated by frameshift mutations.
  •  
2.
  • Ahle, Charlotte M., et al. (författare)
  • Staphylococcus saccharolyticus : An Overlooked Human Skin Colonizer
  • 2020
  • Ingår i: Microorganisms. - : MDPI. - 2076-2607. ; 8:8
  • Tidskriftsartikel (refereegranskat)abstract
    • Coagulase-negative staphylococcal species constitute an important part of the human skin microbiota. In particular, facultative anaerobic species such as Staphylococcus epidermidis and Staphylococcus capitis can be found on the skin of virtually every human being. Here, we applied a culture-independent amplicon sequencing approach to identify staphylococcal species on the skin of healthy human individuals. While S. epidermidis and S. capitis were found as primary residents of back skin, surprisingly, the third most abundant member was Staphylococcus saccharolyticus, a relatively unstudied species. A search of skin metagenomic datasets detected sequences identical to the genome of S. saccharolyticus in diverse skin sites, including the back, forehead, and elbow pit. Although described as a slow-growing anaerobic species, a re-evaluation of its growth behavior showed that S. saccharolyticus can grow under oxic conditions, and, in particular, in a CO2-rich atmosphere. We argue here that S. saccharolyticus was largely overlooked in previous culture-dependent and -independent studies, due to its requirement for fastidious growth conditions and the lack of reference genome sequences, respectively. Future studies are needed to unravel the microbiology and host-interacting properties of S. saccharolyticus and its role as a prevalent skin colonizer.
  •  
3.
  • Ahlstrand, Erik, 1974-, et al. (författare)
  • Alteration of the colonization pattern of coagulase-negative staphylococci in patients undergoing treatment for hematological malignancy
  • 2012
  • Ingår i: European Journal of Clinical Microbiology and Infectious Diseases. - New York, USA : Springer. - 0934-9723 .- 1435-4373. ; 31:7, s. 1679-1687
  • Tidskriftsartikel (refereegranskat)abstract
    • The aim was to prospectively describe the colonization pattern of coagulase-negative staphylococci (CoNS) and the relationship between colonizing and invasive CoNS isolates among patients undergoing treatment for hematological malignancy. Fourteen newly diagnosed patients were included with either multiple myeloma or acute leukemia. Patients were repeatedly sampled from nares, throat, axillae, and perineum, and the CoNS isolates obtained were phenotypically characterized together with blood isolates of CoNS using the PhenePlate system (PhP). During the treatment a gradual reduction in the heterogeneity of colonizing CoNS was observed as well as an inter-patient accumulation of phenotypically related and multi-drug-resistant CoNS. These clusters of CoNS persisted for 2–3 months after the end of therapy. Ten positive blood cultures of CoNS were obtained and in the majority of these cases CoNS of the same PhP type were found in superficial cultures collected prior to the blood culture sampling. In conclusion, the study shows that therapy for hematological malignancy is associated with a homogenization of colonizing CoNS isolates and that this acquired flora of CoNS is persistent several months after the end of therapy. Furthermore, the results suggest that the source of bloodstream infections of CoNS in hematological patients is colonizing CoNS of the skin and mucosa.
  •  
4.
  • Ahlstrand, Erik, 1974-, et al. (författare)
  • Evaluation of a PCR method to determine the clinical significance of blood cultures with Staphylococcus epidermidis in patients with hematological malignancies
  • 2014
  • Ingår i: Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). - : Wiley-Blackwell. - 0903-4641 .- 1600-0463. ; 122:6, s. 539-544
  • Tidskriftsartikel (refereegranskat)abstract
    • The aim was to investigate whether the detection and quantification of Staphylococcus epidermidis DNA in blood could distinguish S. epidermidis blood stream infections (BSIs) from blood culture contaminations in patients with hematological malignancies. The hld gene was chosen to identify S. epidermidis DNA and DNA in blood samples was detected by real-time PCR. Blood samples were obtained simultaneously with blood cultures positive for S. epidermidis (n = 30), during blood culture-negative episodes (n = 10) and episodes of bacteremia with other bacteria than S. epidermidis (n = 4) and from healthy blood donors (n = 10). In addition, DNA from S. epidermidis and a selection of other bacterial species were analyzed. Three different sets of criteria were used to classify episodes with positive blood cultures with S. epidermidis as BSIs or contaminations. All DNA preparations from S. epidermidis (n = 48) were hld-positive, but other bacterial species (n = 13) were negative. Sixteen (53%) of 30 blood samples from patients with blood cultures positive for S. epidermidis were hld-positive, but none of the controls. There was no clear association between a positive hld PCR and episodes interpreted as BSIs. In conclusion, hld PCR failed to distinguish S. epidermidis BSIs from blood culture contaminations in patients with hematological malignancies.
  •  
5.
  • Ahlstrand, Erik, 1974-, et al. (författare)
  • Long-term molecular epidemiology of staphylococcus epidermidis blood culture isolates from patients with hematological malignancies
  • 2014
  • Ingår i: PLOS ONE. - San Francisco, USA : Public Library Science. - 1932-6203. ; 9:6
  • Tidskriftsartikel (refereegranskat)abstract
    • Staphylococcus epidermidis is an important cause of bloodstream infections in patients with hematological malignancies. Knowledge of the long-term epidemiology of these infections is limited. We surveyed all S. epidermidis blood culture isolates from patients treated for hematological malignancies at the University Hospital of Orebro, Sweden from 1980 to 2009. A total of 373 S. epidermidis isolates were identified and multilocus sequence typing, staphylococcal chromosome cassette mec (SCCmec) typing and standard antibiotic susceptibility testing were employed to characterize these isolates. The majority of the isolates 361/373 (97%) belonged to clonal complex 2, and the 373 isolates were divided into 45 sequence types (STs); Simpson's Diversity Index was 0.56. The most prevalent STs were ST2 (243/373, 65%) and ST215 (28/373, 8%). Ninety three percent (226/243) of the ST2 isolates displayed either SCCmec type III or IV. ST2 and 215 were isolated during the entire study period, and together these STs caused temporal peaks in the number of positive blood cultures of S. epidermidis. Methicillin resistance was detected in 213/273 (78%) of all isolates. In the two predominating STs, ST2 and ST215, methicillin resistance was detected in 256/271 isolates (95%), compared with 34/100 (34%) in other STs (p<0.001). In conclusion, in this long-term study of patients with hematological malignancies, we demonstrate a predominance of methicillin-resistant ST2 among S. epidermidis blood culture isolates.
  •  
6.
  • Al Janabi, Jasmina, et al. (författare)
  • Emerging resistance in Staphylococcus epidermidis during dalbavancin exposure : a case report and in vitro analysis of isolates from prosthetic joint infections
  • 2023
  • Ingår i: Journal of Antimicrobial Chemotherapy. - : Oxford University Press. - 0305-7453 .- 1460-2091. ; 78:3, s. 669-677
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Dalbavancin, a semisynthetic lipoglycopeptide with exceptionally long half-life and Gram-positive spectrum, is an attractive option for infections requiring prolonged therapy, including prosthetic joint infections (PJIs).OBJECTIVES: To investigate the prevalence of reduced susceptibility to dalbavancin in a strain collection of Staphylococcus epidermidis from PJIs, and to investigate genomic variation in isolates with reduced susceptibility selected during growth under dalbavancin exposure.METHODS: MIC determination was performed on S. epidermidis isolates from a strain collection (n = 64) and from one patient with emerging resistance during treatment (n = 4). These isolates were subsequently cultured on dalbavancin-containing agar and evaluated at 48 h; MIC determination was repeated if phenotypical heterogeneity was detected during growth. Population analysis profile (PAP-AUC) was performed in isolates where a  ≥ 2-fold increase in MIC was detected, together with corresponding parental isolates (n = 21). Finally, WGS was performed.RESULTS: All strains grew at 48 h on agar containing 0.125 mg/L dalbavancin. PAP-AUC demonstrated significant differences between parental and derived strains in four of the eight analysed groups. An amino acid change in the walK gene coinciding with emergence of phenotypic resistance was detected in the patient isolates, whereas no alterations were found in this region in the in vitro derived strains.CONCLUSIONS: Exposure to dalbavancin may lead to reduced susceptibility to dalbavancin through either selection of pre-existing subpopulations, epigenetic changes or spontaneous mutations during antibiotic exposure. Source control combined with adequate antibiotic concentrations may be important to prevent emerging reduced susceptibility during dalbavancin treatment.
  •  
7.
  • Asfaw Idosa, Berhane, 1977-, et al. (författare)
  • C10X polymorphism in the CARD8 gene is associated with bacteraemia
  • 2014
  • Ingår i: Immunity, inflammation and disease. - West Sussex, UK : John Wiley & Sons. - 2050-4527. ; 2:1, s. 13-20
  • Tidskriftsartikel (refereegranskat)abstract
    • The NLRP3 inflammasome is an intracellular multi-protein complex that triggers caspase-1 mediated maturation of interleukin-1β (IL-1β); one of the most potent mediators of inflammation and a major cytokine produced during severe infections, like sepsis. However, the excessive cytokine levels seem to stage for tissue injury and organ failure, and high levels of IL-1β correlates with severity and mortality of sepsis. Instead, recent data suggest caspase-1 to function as a guardian against severe infections. CARD8 has been implied to regulate the synthesis of IL-1β via interaction to caspase-1. In recent years, polymorphism of CARD8 (C10X) per se or in combination with NLRP3 (Q705K) has been implicated with increased risk of inflammation. The aim was to investigate the correlation of these polymorphisms with severe blood stream infection. Human DNA was extracted from blood culture bottles that were found to be positive for microbial growth (i.e. patients with bacteraemia). Polymorphisms Q705K in the NLRP3 gene and C10X in the CARD8 gene were genotyped using TaqMan genotyping assay. The results were compared to healthy controls and to samples from patients with negative cultures. The polymorphism C10X was significantly over-represented among patients with bacteraemia as compared to healthy controls, whereas patients with negative blood culture were not associated with a higher prevalence. No association was observed with polymorphism Q705K of NLRP3 in either group of patients. Patients carrying polymorphism C10X in the CARD8 gene are at increased risk of developing bacteraemia and severe inflammation.
  •  
8.
  • Bang, Charlotte Sahlberg, 1967-, et al. (författare)
  • Multiresistant uropathogenic extended-spectrum β-lactamase (ESBL)-producing Escherichia coli are susceptible to the carbon monoxide releasing molecule-2 (CORM-2).
  • 2014
  • Ingår i: Microbial Pathogenesis. - London : Elsevier. - 0882-4010 .- 1096-1208. ; 66, s. 29-35
  • Tidskriftsartikel (refereegranskat)abstract
    • Carbon monoxide (CO) releasing molecules (CO-RMs) have been shown to inhibit growth of commensal Escherichia coli (E. coli). In the present study we examined the effect of CORM-2 on uropathogenic E. coli (UPEC) that produces extended-spectrum β-lactamase (ESBL). Viability experiments showed that CORM-2 inhibited the growth of several different ESBL-producing UPEC isolates and that 500 μM CORM-2 had a bactericidal effect within 4 h. The bactericidal effect of CORM-2 was significantly more pronounced than the effect of the antibiotic nitrofurantoin. CORM-2 demonstrated a low level of cytotoxicity in eukaryotic cells (human bladder epithelial cell line 5637) at the concentrations and time-points where the antibacterial effect was obtained. Real-time RT-PCR studies of different virulence genes showed that the expression of capsule group II kpsMT II and serum resistance traT was reduced and that some genes encoding iron acquisition systems were altered by CORM-2. Our results demonstrate that CORM-2 has a fast bactericidal effect against multiresistant ESBL-producing UPEC isolates, and also identify some putative UPEC virulence factors as targets for CORM-2. CO-RMs may be candidate drugs for further studies in the field of finding new therapeutic approaches for treatment of uropathogenic ESBLproducing E. coli.
  •  
9.
  • Bang, Charlotte Sahlberg, 1967-, et al. (författare)
  • The antibacterial effect of nitric oxide against ESBL-producing uropathogenic E-coli is improved by combination with miconazole and polymyxin B nonapeptide
  • 2014
  • Ingår i: BMC Microbiology. - London : BioMed Central. - 1471-2180. ; 14
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Nitric oxide (NO) is produced as part of the host immune response to bacterial infections, including urinary tract infections. The enzyme flavohemoglobin, coded by the hmp gene, is involved in protecting bacterial cells from the toxic effects of NO and represents a potentially interesting target for development of novel treatment concepts against resistant uropathogenic bacteria. The aim of the present study was to investigate if the in vitro antibacterial effects of NO can be enhanced by pharmacological modulation of the enzyme flavohemoglobin.Results: Four clinical isolates of multidrug-resistant extended-spectrum beta-lactamase (ESBL)-producing uropathogenic E. coli were included in the study. It was shown that the NO-donor substance DETA/NO, but not inactivated DETA/NO, caused an initial growth inhibition with regrowth noted after 8 h of exposure. An hmp-deficient strain showed a prolonged growth inhibition in response to DETA/NO compared to the wild type. The imidazole antibiotic miconazole, that has been shown to inhibit bacterial flavohemoglobin activity, prolonged the DETA/NO-evoked growth inhibition. When miconazole was combined with polymyxin B nonapeptide (PMBN), in order to increase the bacterial wall permeability, DETA/NO caused a prolonged bacteriostatic response that lasted for up to 24 h.Conclusion: An NO-donor in combination with miconazole and PMBN showed enhanced antimicrobial effects and proved effective against multidrug-resistant ESBL-producing uropathogenic E. coli.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 156
Typ av publikation
tidskriftsartikel (121)
annan publikation (19)
doktorsavhandling (10)
bok (2)
konferensbidrag (2)
forskningsöversikt (2)
visa fler...
visa färre...
Typ av innehåll
refereegranskat (123)
övrigt vetenskapligt/konstnärligt (33)
Författare/redaktör
Hellmark, Bengt, 197 ... (24)
Tevell, Staffan, 197 ... (14)
Stegger, Marc (13)
Stegger, Marc, 1975- (12)
Mölling, Paula (11)
visa fler...
Brüggemann, Holger (11)
Söderquist, Bo, prof ... (10)
Strålin, Kristoffer (9)
Unemo, Magnus, 1970- (9)
Monecke, Stefan (9)
Lindblad, Birgitta E ... (9)
Sid Ahmed, Mazen, 19 ... (8)
Poehlein, Anja (8)
Cajander, Sara, 1980 ... (8)
Särndahl, Eva, 1963- (8)
Rasmussen, Gunlög, 1 ... (8)
Stenmark, Bianca, 19 ... (7)
Källman, Jan, 1958- (7)
Sundqvist, Martin, 1 ... (7)
Davidsson, Sabina, 1 ... (7)
Friberg, Örjan (6)
Andren, Ove, 1963- (6)
Bäckman, Anders, 195 ... (6)
Hugosson, Svante, 19 ... (6)
Ibrahim, Emad Bashir (5)
Nilsson, Ulrica, 196 ... (5)
Sahdo, Berolla, 1984 ... (5)
Önnberg, Anna, 1980- (5)
Carlsson, Jessica, 1 ... (5)
Müller, Elke (5)
Afshar, Mastaneh (4)
Cao, Yang, Associate ... (4)
Baig, Sharmin (4)
Persson, Katarina, 1 ... (4)
Tina, Elisabet, 1975 ... (4)
Magnuson, Anders (3)
Wretenberg, Per, 196 ... (3)
Ahlstrand, Erik, 197 ... (3)
Persson, Lennart (3)
Lilje, Berit (3)
Johannesen, Thor Bec ... (3)
Elgh, Fredrik (3)
Jensen, Anders (3)
Asfaw Idosa, Berhane ... (3)
Kelly, Anne, 1978- (3)
Demirel, Isak, 1987- (3)
Brinkmann, Volker (3)
Brzuszkiewicz, Elzbi ... (3)
Al-Zeer, Munir A. (3)
visa färre...
Lärosäte
Örebro universitet (156)
Linköpings universitet (22)
Karolinska Institutet (13)
Uppsala universitet (7)
Umeå universitet (5)
Göteborgs universitet (3)
visa fler...
Karlstads universitet (1)
visa färre...
Språk
Engelska (155)
Svenska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (135)
Naturvetenskap (26)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy